Perspective Therapeutics, Inc. – NYSE:CATX
Perspective Therapeutics stock price today
$3.4
+0.20
+6.58%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 15 hours
Perspective Therapeutics stock price monthly change
-75.29%
month
Perspective Therapeutics stock price quarterly change
-75.29%
quarter
Perspective Therapeutics stock price yearly change
+571.86%
year
Perspective Therapeutics key metrics
Market Cap | 198.03M |
Enterprise value | 77.62M |
P/E | -11.52 |
EV/Sales | 8.65 |
EV/EBITDA | -8.10 |
Price/Sales | 10.95 |
Price/Book | 1.78 |
PEG ratio | 0.16 |
EPS | -0.09 |
Revenue | 7.07M |
EBITDA | -34.64M |
Income | -24.03M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -115.91% |
Oper. margin | -121.48% |
Gross margin | 35.51% |
EBIT margin | -121.48% |
EBITDA margin | -489.69% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePerspective Therapeutics stock price history
Perspective Therapeutics stock forecast
Perspective Therapeutics financial statements
Average Price Target
$21
Potential upside: 517.64%
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 1.83M | -2.19M | -119.84% |
|---|---|---|---|
| Mar 2023 | 1.83M | -371K | -20.27% |
| Jun 2023 | 1.5M | -11.10M | -740.4% |
| Sep 2023 | 1.90M | -10.35M | -542.48% |
| 2023-02-16 | -0.01 | -0.02 |
|---|---|---|
| 2023-05-15 | -0.01 | -0.01 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 0% |
|---|---|
| 2020 | 0% |
| 2022 | |
| 2022 | |
| 2023 |
| Dec 2021 | 67252000 | 2.86M | 4.25% |
|---|---|---|---|
| Sep 2022 | 62538000 | 4.83M | 7.73% |
| Dec 2022 | 58277000 | 3.26M | 5.61% |
| Sep 2023 | 110518000 | 11.74M | 10.63% |
| Sep 2022 | -1.76M | -35.16M | 28K |
|---|---|---|---|
| Mar 2023 | -9.72M | 25.26M | -80K |
| Jun 2023 | -8.07M | -573K | 512K |
| Sep 2023 | -10.11M | -227K | 1K |
Perspective Therapeutics alternative data
| Aug 2023 | 66 |
|---|---|
| Sep 2023 | 91 |
| Oct 2023 | 91 |
| Nov 2023 | 91 |
| Dec 2023 | 91 |
| Jan 2024 | 91 |
| Feb 2024 | 91 |
| Mar 2024 | 91 |
| Apr 2024 | 91 |
| May 2024 | 116 |
| Jun 2024 | 116 |
| Jul 2024 | 116 |
Perspective Therapeutics other data
7.68%
+7.67%
of CATX is owned by hedge funds
26
+25
10.90M
+10.89M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 595081 | 0 |
| Mar 2024 | 60431039 | 0 |
| May 2024 | 110037 | 0 |
| Jun 2024 | 140633 | 0 |
| Nov 2024 | 45595 | 0 |
| Dec 2024 | 33975 | 0 |
| Quarter | Transcript |
|---|---|
| Q1 2023 10 Nov 2022 | Q1 2023 Earnings Call Transcript |
| Q4 2022 28 Sep 2022 | Q4 2022 Earnings Call Transcript |
| Q3 2022 10 May 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 8 Feb 2022 | Q2 2022 Earnings Call Transcript |
-
What's the price of Perspective Therapeutics stock today?
One share of Perspective Therapeutics stock can currently be purchased for approximately $3.4.
-
When is Perspective Therapeutics's next earnings date?
Unfortunately, Perspective Therapeutics's (CATX) next earnings date is currently unknown.
-
Does Perspective Therapeutics pay dividends?
No, Perspective Therapeutics does not pay dividends.
-
How much money does Perspective Therapeutics make?
Perspective Therapeutics has a market capitalization of 198.03M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 79.81% to 1.43M US dollars. Perspective Therapeutics made a loss 46.51M US dollars in net income (profit) last year or -$0.01 on an earnings per share basis.
-
What is Perspective Therapeutics's stock symbol?
Perspective Therapeutics, Inc. is traded on the NYSE under the ticker symbol "CATX".
-
What is Perspective Therapeutics's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Perspective Therapeutics?
Shares of Perspective Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Perspective Therapeutics have?
As Jul 2024, Perspective Therapeutics employs 116 workers, which is 27% more then previous quarter.
-
When Perspective Therapeutics went public?
Perspective Therapeutics, Inc. is publicly traded company for more then 19 years since IPO on 10 Nov 2005.
-
What is Perspective Therapeutics's official website?
The official website for Perspective Therapeutics is perspectivetherapeutics.com.
-
Where are Perspective Therapeutics's headquarters?
Perspective Therapeutics is headquartered at 350 Hills Street, Richland, WA.
-
How can i contact Perspective Therapeutics?
Perspective Therapeutics's mailing address is 350 Hills Street, Richland, WA and company can be reached via phone at +509 3751202.
-
What is Perspective Therapeutics stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Perspective Therapeutics in the last 12 months, the avarage price target is $21. The average price target represents a 517.64% change from the last price of $3.4.
Perspective Therapeutics company profile:
Perspective Therapeutics, Inc.
perspectivetherapeutics.comExchange:
NYSE
Full time employees:
116
Industry:
Medical - Devices
Sector:
Healthcare
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
350 Hills Street
Richland, WA 99354
Richland, WA 99354
CIK: 0000728387
ISIN: US46489V1044
:
